Evidence map›Paper›PMID 32309411›Full record

ReviewAnnals of translational medicine2020

Efficiency and risks of one-anastomosis gastric bypass.

Rene Aleman, Emanuele Lo Menzo, Samuel Szomstein, Raul J Rosenthal

Registry-linked trialAbstract readReview
In one paragraph

Review in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06970093 (One Anastomosis Gastric Bypass), which is not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06970093 nacompletednot on this mapstarted 2024, after this paper: background citation

One Anastomosis Gastric Bypass (OAGB) vs Duodeno-jejunostomy For Treatment of Superior Mesenteric Artery Syndrome: A Prospective Randomized Control Trial

TypeinterventionalSponsorAin Shams UniversityRan2024 to 2025Enrolled20ConditionsSuperior Mesenteric Artery Syndrome, Duodenal Obstruction, Weight Loss, Gastrointestinal DiseaseArmsOne Anastomosis Gastric Bypass, Duodenojejunostomy
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rene AlemanDepartment of General Surgery, Section of Minimally Invasive Surgery, The Bariatric & Metabolic Institute, Cleveland Clinic Florida, Weston, FL, USA.
Emanuele Lo MenzoDepartment of General Surgery, Section of Minimally Invasive Surgery, The Bariatric & Metabolic Institute, Cleveland Clinic Florida, Weston, FL, USA.
Samuel SzomsteinDepartment of General Surgery, Section of Minimally Invasive Surgery, The Bariatric & Metabolic Institute, Cleveland Clinic Florida, Weston, FL, USA.
Raul J RosenthalDepartment of General Surgery, Section of Minimally Invasive Surgery, The Bariatric & Metabolic Institute, Cleveland Clinic Florida, Weston, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The single-anastomosis gastric bypass has been proposed as a simpler and efficient weight loss reducing surgery. Postoperative outcomes are comparable to those of contemporary popular procedures. There are, however, controversies regarding the efficiency and risks of one-anastomosis gastric bypass (OAGB). The purpose of this review is to define the role of OAGB in metabolic surgery via its operative outcomes. A review of English language literature was performed using the PubMed database, basing the search on the following keywords: "one-anastomosis gastric bypass" AND "outcomes". A total of 238 articles were considered for review. Following thorough screening and selection criteria, 7 articles were considered sufficient for assessment. The nature of the available evidence of this technique poses a challenge to OAGB in its establishment as a standard of care procedure. The anatomical configuration following surgery, as well as the metabolic implications of its hypo-absorptive nature, raises controversial and ongoing concerns that are yet to be addressed. Hence, prospective studies with long-term follow-up (>5 years) can bypass these concerns and allow the progression of the clinical practice of OAGB.

Indexed as

bariatric surgerymini gastric bypassobesityOne-anastomosis gastric bypass (OAGB)single anastomosis gastric bypassweight loss

Identifiers

PMID32309411
PMCPMC7154323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.